Vidal Christian, Skripuletz Thomas
Klinische Chemie, Medizinische Hochschule Hannover, Hannover, Germany.
Ther Drug Monit. 2007 Jun;29(3):373-5. doi: 10.1097/FTD.0b013e318040adc3.
A 50-year-old male patient suddenly had lost consciousness, although he had previously been healthy. On arrival at hospital seizures arose. The authors investigated a urine sample of the patient, and performed toxicological drug screening with immunochemical Cloned Enzyme Donor Immunoassay (CEDIA) assays. Positive findings for amphetamines and LSD could not be confirmed. Using gas chromatography/mass spectrometry (GC/MS), and liquid chromatography/mass spectrometry (LC/MS), the authors identified bupropion, a drug used to aid in smoking cessation, as the interfering compound, which may cause false-positive results for amphetamines and LSD using the CEDIA assays.
一名50岁男性患者,此前身体健康,却突然失去意识。入院后出现癫痫发作。作者对该患者的尿液样本进行了调查,并采用免疫化学克隆酶供体免疫分析(CEDIA)法进行毒理学药物筛查。苯丙胺和麦角酸二乙酰胺(LSD)的阳性结果无法得到证实。作者使用气相色谱/质谱联用仪(GC/MS)和液相色谱/质谱联用仪(LC/MS),鉴定出安非他酮(一种用于辅助戒烟的药物)为干扰化合物,它可能会导致使用CEDIA分析法时出现苯丙胺和LSD的假阳性结果。